Chiasma, Inc (CHMA)

Trade CHMA now with
3/20/2021 11:40:36 AM Chiasma Presents Positive Data For MYCAPSSA From Phase 3 Trial MPOWERED For Maintenance Treatment Of Acromegaly At ENDO
8/31/2020 8:05:47 AM Chiasma Reports U.S. Commercial Launch And Availability Of MYCAPSSA
8/17/2020 8:15:47 AM Chiasma Reports Publication Of Pivotal Data From Phase 3 CHIASMA OPTIMAL Clinical Trial
7/1/2020 9:16:10 AM Chiasma Prices Public Offering Of 12.50 Mln Shares
4/8/2020 7:10:51 AM Chiasma Announces Entry Into Revenue Interest Financing Agreement With HCR
1/13/2020 7:17:58 AM Chiasma: FDA Accepts For Review The NDA Resubmission For MYCAPSSA
7/26/2019 9:09:34 AM Chiasma Prices Underwritten Public Offering Of 10 Mln Shares At $5.50/shr
7/23/2019 6:12:40 AM Chiasma Announces Positive Phase 3 Top-Line Results From CHIASMA OPTIMAL Clinical Trial Of Mycapssa
3/20/2018 4:09:37 PM Chiasma Q4 Loss/share $0.25 Vs. Loss $0.32 Year Ago
3/16/2018 8:06:34 AM Chiasma Announces Poster Presentation Of Phase 3 Double-Blind Trial Of Oral Octreotide Capsules Vs Placebo